Leading Lea. Fin (540360)

Fast Grower

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹3.24
Market Cap₹143.72 Cr
P/E Ratio4.41
ROCE7.82%
ROE182.33%
Dividend Yield0%
Profit Growth1,000%
Debt/Equity
Sales Growth594.05%
52-Week Range₹1.25 — ₹6.18
SectorFinance
Book Value₹0.17

Strengths

Concerns

AI Analysis

At first glance, this looks like every growth investor's dream at a value price: P/E of 4.41, PEG of 0.01, sales up 594%, profits up 1000%. But Benjamin Graham taught me to never judge a business by a dazzling income statement alone. This is a non-banking financial company, and for a lender, the balance sheet is the real story. Here the story is worrying. Book value is just ₹0.17 per share. At ₹3.24 I am paying over 19 times book for an equity cushion that thin. In finance, a small mistake in loans can wipe out shareholders. The 182% ROE is mathematically exciting, but ROCE of only 7.82% tells me the high return is likely being manufactured by leverage, not by superior operations. And debt-to-equity is not available. That is not acceptable for an NBFC. The latest quarter—sales of ₹64 Cr and net profit of ₹18 Cr—is strong, and the market cap of ₹144 Cr means if these earnings continue, the stock is cheap. But I have seen many Indian financials where one good quarter and explosive growth from a low base create a seductive P/E. The 52-week range of ₹1.25 to ₹7.10 shows how speculative this can be. With no dividend, I am relying entirely on the business to reinvest and compound. The Piotroski score of 7/9 is encouraging, but it does not replace audit quality, disclosure, and a known promoter. I cannot make a Graham-style investment when I don't know who controls the company, what the leverage is, and whether the equity base can absorb shocks. This is a fast grower with a value P/E, but that combination only works if the balance sheet and governance hold up. Today, the figures are not enough.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer